rs747789914

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PP3_StrongBS2

The NM_021098.3(CACNA1H):​c.5162G>A​(p.Arg1721His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,609,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

17
1
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 9.71

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.947
BS2
High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5162G>A p.Arg1721His missense_variant Exon 29 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5162G>A p.Arg1721His missense_variant Exon 29 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5177G>A p.Arg1726His missense_variant Exon 28 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5180G>A p.Arg1727His missense_variant Exon 28 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5144G>A p.Arg1715His missense_variant Exon 28 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5177G>A p.Arg1726His missense_variant Exon 29 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5162G>A p.Arg1721His missense_variant Exon 29 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5123G>A p.Arg1708His missense_variant Exon 29 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5144G>A p.Arg1715His missense_variant Exon 28 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5105G>A p.Arg1702His missense_variant Exon 28 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5162G>A p.Arg1721His missense_variant Exon 29 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5144G>A p.Arg1715His missense_variant Exon 28 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5162G>A p.Arg1721His missense_variant Exon 29 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.5162G>A p.Arg1721His missense_variant Exon 29 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.5162G>A p.Arg1721His missense_variant Exon 29 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.5162G>A non_coding_transcript_exon_variant Exon 29 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1114G>A non_coding_transcript_exon_variant Exon 28 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*243G>A non_coding_transcript_exon_variant Exon 29 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3013G>A non_coding_transcript_exon_variant Exon 29 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*4606G>A non_coding_transcript_exon_variant Exon 27 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.5144G>A non_coding_transcript_exon_variant Exon 28 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.5144G>A non_coding_transcript_exon_variant Exon 28 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*163G>A non_coding_transcript_exon_variant Exon 29 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.5162G>A non_coding_transcript_exon_variant Exon 29 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.5162G>A non_coding_transcript_exon_variant Exon 29 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5144G>A non_coding_transcript_exon_variant Exon 28 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5162G>A non_coding_transcript_exon_variant Exon 29 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5162G>A non_coding_transcript_exon_variant Exon 29 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*163G>A non_coding_transcript_exon_variant Exon 28 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1114G>A 3_prime_UTR_variant Exon 28 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*243G>A 3_prime_UTR_variant Exon 29 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3013G>A 3_prime_UTR_variant Exon 29 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*4606G>A 3_prime_UTR_variant Exon 27 of 34 ENSP00000518758.1
CACNA1HENST00000711451.1 linkn.*163G>A 3_prime_UTR_variant Exon 29 of 36 ENSP00000518763.1
CACNA1HENST00000711488.1 linkn.*163G>A 3_prime_UTR_variant Exon 28 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.0000330
AC:
5
AN:
151646
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000192
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000295
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000369
AC:
9
AN:
243956
AF XY:
0.0000376
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000143
Gnomad NFE exome
AF:
0.0000454
Gnomad OTH exome
AF:
0.000168
GnomAD4 exome
AF:
0.0000171
AC:
25
AN:
1457994
Hom.:
0
Cov.:
33
AF XY:
0.0000193
AC XY:
14
AN XY:
725148
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33422
American (AMR)
AF:
0.0000449
AC:
2
AN:
44542
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26006
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39586
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
85916
European-Finnish (FIN)
AF:
0.000193
AC:
10
AN:
51882
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000108
AC:
12
AN:
1110658
Other (OTH)
AF:
0.00
AC:
0
AN:
60230
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000330
AC:
5
AN:
151646
Hom.:
0
Cov.:
33
AF XY:
0.0000270
AC XY:
2
AN XY:
74110
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41378
American (AMR)
AF:
0.0000655
AC:
1
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4790
European-Finnish (FIN)
AF:
0.000192
AC:
2
AN:
10428
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000295
AC:
2
AN:
67858
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000510
Hom.:
0
Bravo
AF:
0.0000416
ExAC
AF:
0.0000414
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Nov 21, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Mar 17, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.5162G>A (p.R1721H) alteration is located in exon 29 (coding exon 28) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 5162, causing the arginine (R) at amino acid position 1721 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Aug 15, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is present in population databases (rs747789914, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. ClinVar contains an entry for this variant (Variation ID: 585648). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1721 of the CACNA1H protein (p.Arg1721His). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Mar 12, 2018
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Pathogenic
0.43
D
BayesDel_noAF
Pathogenic
0.52
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.93
D;.;.;.
Eigen
Pathogenic
0.86
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
D;D;D;.
M_CAP
Pathogenic
0.82
D
MetaRNN
Pathogenic
0.95
D;D;D;D
MetaSVM
Pathogenic
0.99
D
MutationAssessor
Pathogenic
4.7
H;.;.;.
PhyloP100
9.7
PrimateAI
Pathogenic
0.91
D
PROVEAN
Pathogenic
-5.0
D;.;D;D
REVEL
Pathogenic
0.94
Sift
Pathogenic
0.0
D;.;D;D
Sift4G
Pathogenic
0.0
D;.;D;D
Polyphen
1.0
D;.;D;D
Vest4
0.84
MVP
0.98
ClinPred
1.0
D
GERP RS
3.8
Varity_R
0.95
gMVP
0.94
Mutation Taster
=42/58
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747789914; hg19: chr16-1265364; API